Indoxyl sulfate induces endothelial cell senescence by increasing reactive oxygen species production and p53 activity. 2012

Yelixiati Adelibieke, and Hidehisa Shimizu, and Gulinuer Muteliefu, and Dilinaer Bolati, and Toshimitsu Niwa
Department of Advanced Medicine for Uremia, Nagoya University School of Medicine, Tsurumai-cho, Showa-ku, Nagoya, Japan.

OBJECTIVE We have reported that indoxyl sulfate (IS), a uremic toxin, accelerates proximal tubular cell senescence. Asymmetric dimethylarginine (ADMA), an inhibitor of nitric oxide synthase, has been reported to induce endothelial cell senescence. This study aimed to determine whether IS induces endothelial cell senescence in comparison with ADMA, and to investigate its molecular mechanism. METHODS Human umbilical vein endothelial cells (HUVECs) were incubated with IS (250 μM) and/or ADMA (10 μM). These concentrations were comparable with their mean serum levels in hemodialysis patients. Cell senescence was evaluated by measuring senescence-associated beta-galactosidase (SA-β-gal) activity. N-acetylcysteine, an antioxidant, and pifithrin alpha p-nitro, a p53 inhibitor, were used to determine the role of reactive oxygen species (ROS) and p53 in the induction of cell senescence. RESULTS Both IS and ADMA significantly increased SA-β-gal activity in HUVECs. Further, some additional increase in SA-β-gal activity was observed when IS and ADMA were co-incubated. Preincubation of N-acetylcysteine or pifithrin alpha p-nitro significantly inhibited SA-β-gal activity induced by IS and ADMA in HUVECs. Thus, both IS and ADMA induced endothelial senescence through ROS and p53. CONCLUSIONS IS induces endothelial cell senescence by increasing ROS production and p53 activity, like ADMA.

UI MeSH Term Description Entries
D007200 Indican A substance occurring in the urine of mammals and also in blood plasma as the normal metabolite of tryptophan. An increased urinary excretion of indican is seen in Hartnup disease from the bacterial degradation of unabsorbed tryptophan. 1H-Indol-3-ol Hydrogen Sulfate Ester,Indican Monopotassium Salt,Indican Monosodium Salt,Indoxyl Sulfate,Monopotassium Salt, Indican,Monosodium Salt, Indican,Sulfate, Indoxyl
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001120 Arginine An essential amino acid that is physiologically active in the L-form. Arginine Hydrochloride,Arginine, L-Isomer,DL-Arginine Acetate, Monohydrate,L-Arginine,Arginine, L Isomer,DL Arginine Acetate, Monohydrate,Hydrochloride, Arginine,L Arginine,L-Isomer Arginine,Monohydrate DL-Arginine Acetate
D016159 Tumor Suppressor Protein p53 Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER. p53 Tumor Suppressor Protein,Cellular Tumor Antigen p53,Oncoprotein p53,TP53 Protein,TRP53 Protein,p53 Antigen,pp53 Phosphoprotein,Phosphoprotein, pp53
D016922 Cellular Senescence Process by which cells irreversibly stop dividing and enter a state of permanent growth arrest without undergoing CELL DEATH. Senescence can be induced by DNA DAMAGE or other cellular stresses, such as OXIDATIVE STRESS. Aging, Cell,Cell Aging,Cell Senescence,Replicative Senescence,Senescence, Cellular,Senescence, Replicative,Cell Ageing,Cellular Ageing,Cellular Aging,Ageing, Cell,Ageing, Cellular,Aging, Cellular,Senescence, Cell
D017382 Reactive Oxygen Species Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS. Active Oxygen Species,Oxygen Radical,Oxygen Radicals,Pro-Oxidant,Reactive Oxygen Intermediates,Active Oxygen,Oxygen Species, Reactive,Pro-Oxidants,Oxygen, Active,Pro Oxidant,Pro Oxidants,Radical, Oxygen
D061307 Human Umbilical Vein Endothelial Cells Endothelial cells that line venous vessels of the UMBILICAL CORD. Human Umbilical Vein Endothelial Cell,Endothelial Cells, Human Umbilical Vein,HUVEC Cells,Cell, HUVEC,Cells, HUVEC,HUVEC Cell
D019001 Nitric Oxide Synthase An NADPH-dependent enzyme that catalyzes the conversion of L-ARGININE and OXYGEN to produce CITRULLINE and NITRIC OXIDE. NO Synthase,Nitric-Oxide Synthase,Nitric-Oxide Synthetase,Nitric Oxide Synthetase,Oxide Synthase, Nitric,Synthase, Nitric Oxide

Related Publications

Yelixiati Adelibieke, and Hidehisa Shimizu, and Gulinuer Muteliefu, and Dilinaer Bolati, and Toshimitsu Niwa
August 2019, Toxins,
Yelixiati Adelibieke, and Hidehisa Shimizu, and Gulinuer Muteliefu, and Dilinaer Bolati, and Toshimitsu Niwa
January 2012, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation,
Yelixiati Adelibieke, and Hidehisa Shimizu, and Gulinuer Muteliefu, and Dilinaer Bolati, and Toshimitsu Niwa
August 2002, Circulation,
Yelixiati Adelibieke, and Hidehisa Shimizu, and Gulinuer Muteliefu, and Dilinaer Bolati, and Toshimitsu Niwa
August 2021, Annals of translational medicine,
Yelixiati Adelibieke, and Hidehisa Shimizu, and Gulinuer Muteliefu, and Dilinaer Bolati, and Toshimitsu Niwa
April 2011, Hypertension research : official journal of the Japanese Society of Hypertension,
Yelixiati Adelibieke, and Hidehisa Shimizu, and Gulinuer Muteliefu, and Dilinaer Bolati, and Toshimitsu Niwa
May 2018, Molecular medicine reports,
Yelixiati Adelibieke, and Hidehisa Shimizu, and Gulinuer Muteliefu, and Dilinaer Bolati, and Toshimitsu Niwa
March 2013, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
Yelixiati Adelibieke, and Hidehisa Shimizu, and Gulinuer Muteliefu, and Dilinaer Bolati, and Toshimitsu Niwa
January 2016, Free radical research,
Yelixiati Adelibieke, and Hidehisa Shimizu, and Gulinuer Muteliefu, and Dilinaer Bolati, and Toshimitsu Niwa
September 2016, Nephrology (Carlton, Vic.),
Yelixiati Adelibieke, and Hidehisa Shimizu, and Gulinuer Muteliefu, and Dilinaer Bolati, and Toshimitsu Niwa
May 2021, Cell stress & chaperones,
Copied contents to your clipboard!